Intended Use
The objective intent of the manufacturer regarding the use of the device.
Definition
Intended use is the use for which a product is intended according to the data supplied by the manufacturer in labeling, advertising, and promotional materials.What this means in practice
Intended use defines the device, drives classification, and is the anchor for risk analysis and labeling. Off-label promotion is a regulatory violation.Examples
- A manufacturer states their software is intended to assist clinicians in diagnosing melanoma from dermatoscopic images, which defines its intended use.
- A blood glucose meter is marketed for self-monitoring by individuals with diabetes, establishing its intended use for patient management of a chronic condition.
- An orthopedic implant
- •A poorly defined intended use can lead to incorrect device classification, impacting regulatory pathway and submission requirements.
- •Failing to clearly articulate the intended use can result in inadequate risk management activities, as potential hazards may be overlooked.
- •Marketing or promoting a device for uses outside its stated intended use constitutes off-label promotion, which is a regulatory violation.
- •Modifying the intended use of a device without proper regulatory notification or submission can lead to non-compliance and enforcement actions.
- •Overly broad or vague intended use statements can create ambiguity and make it difficult to demonstrate conformity with essential requirements or safety and performance principles.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related concepts510(k) Fundamentals
· From this learning pathThe legal standard a 510(k) device must meet versus a predicate.
FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
Pathway to classify novel low- to moderate-risk devices that lack a predicate.
A legally marketed device used as the comparator in a 510(k) submission.
De Novo & Breakthrough Pathways
· From this learning pathVoluntary mechanism to obtain FDA feedback before a formal premarket submission.
FDA program providing expedited review for devices that treat life-threatening or irreversibly debilitating conditions.
Product comprised of two or more regulated components - e.g., drug-device, biologic-device.
FDA's most stringent device marketing application, required for high-risk Class III devices.
Mentioned in recent activity
2 entriesLatest in MedTech
Recent regulatory actions, publications, and trials matched to this term. Updated daily.
-
PubMed2026-06-11B1+rms for Implants: A Review of Intended Use.
Journal of magnetic resonance imaging : JMRI
Primary references
3 sources- 1
21 CFR 801.4VerifiedeCFRecfr.gov
- 2
European Commission - Medical DevicesVerifiedEuropean Commissionhealth.ec.europa.eu
- 3
IMDRF DocumentsVerifiedIMDRFimdrf.org
Inline markers like [1] jump to the matching reference above.